Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02817425 | A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 300 | LanZhou UniversityOTHER | 1 | Jun 29, 2016 | clinicaltrials |
| NCT01100801 | A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients(3G) | unknown | Phase 2 | 90 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 |
| clinicaltrials |
| NCT01227772 | Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 23 | National University Hospital, SingaporeOTHER | 3 | Jun 22, 2016 | clinicaltrials |
| NCT01228045 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | unknown | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02030561 | NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer | unknown | Phase 1 / Phase 2 | 29 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02805829 | Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer | unknown | Phase 1 / Phase 2 | 20 | Xuzhou Medical UniversityOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01542294 | SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer | unknown | Phase 1 / Phase 2 | 71 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT01739894 | Feasibility Study of Intraperitoneal Paclitaxel | unknown | Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT02317471 | Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 45 | Chinese PLA General HospitalOTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT02215837 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | unknown | Phase 2 | 40 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02572050 | Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection(AaRon) | unknown | Phase 2 | 87 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02388581 | First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL | unknown | Phase 2 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02632201 | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT01618474 | Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients | unknown | Phase 2 | 100 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02623153 | Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 | 200 | Tianshu LiuOTHER | 0 | Dec 7, 2015 | clinicaltrials |
| NCT02409199 | A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer | unknown | Phase 2 / Phase 3 | 66 | Shanghai Zhongshan HospitalOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01088204 | Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer(COACT_1001) | unknown | Phase 2 | 204 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 7, 2015 | clinicaltrials |
| NCT02549911 | HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis | unknown | Phase 2 | 40 | Zhejiang Cancer HospitalOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT02525237 | Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 30 | Qingdao Municipal HospitalOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02504229 | DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment | unknown | Phase 2 | 80 | Beijing Biohealthcare Biotechnology Co.,LtdINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00674167 | The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma | unknown | Phase 2 | 21 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2015 | clinicaltrials |
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | unknown | Phase 2 | 160 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02413476 | Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy | unknown | Phase 2 / Phase 3 | 120 | wei boOTHER | 0 | May 19, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT02423278 | The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT01980407 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 49 | Jilin Provincial Tumor HospitalOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01674959 | Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 5, 2015 | clinicaltrials |
| NCT02311595 | A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection | unknown | Phase 2 | 67 | Samsung Medical CenterOTHER | 0 | Dec 8, 2014 | clinicaltrials |
| NCT02291211 | S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis | unknown | Phase 2 | 60 | Tang-Du HospitalOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT02250209 | T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy | unknown | Phase 2 | 40 | Chinese PLA General HospitalOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT02226380 | FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer(FOLFOX6) | unknown | Phase 2 | 75 | Peking Union Medical College HospitalOTHER | 1 | Aug 27, 2014 | clinicaltrials |
| NCT00004236 | Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT02163291 | Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer | unknown | Phase 2 | 30 | Peking UniversityOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT02072317 | Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 140 | Fudan UniversityOTHER | 1 | Feb 26, 2014 | clinicaltrials |
| NCT01584336 | Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)(KLASS-03) | unknown | Phase 2 | 168 | Soonchunhyang University HospitalOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT02038621 | The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer(GZH-001) | unknown | Phase 2 | 224 | The Second People's Hospital of SichuanOTHER | 0 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT02024217 | Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma(NEWEAR) | unknown | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00005607 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | unknown | Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005876 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01963702 | A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01180166 | Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer | unknown | Phase 2 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00088816 | S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer | unknown | Phase 2 | 50 | Kyoto UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00134095 | S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | unknown | Phase 2 | 70 | Fukushima Medical University HospitalOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01798251 | XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach | unknown | Phase 2 | 40 | Harbin Medical UniversityOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT01836991 | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer | unknown | Phase 2 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01836120 | A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT01795768 | Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours(FGFR) | unknown | Phase 2 | 48 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 15, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Jun 29, 2016source: clinicaltrials